相关实验视频
Updated: Jan 7, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
与肥胖相关的淋巴细胞病变,肥胖流行病中脏负担越来越大
Mahtab Mashayekhi1, Jonathan E Zuckerman2, Sahar H Koubar3
1Division of Nephrology, Department of Medicine, Loma Linda University Medical Center, Loma Linda, CA, USA.
肥胖会通过多种途径加速病的进展,导致肥胖相关的淋巴细胞病变 (ORG). 减肥和新疗法是解决这种日益严重的健康问题的关键.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肥胖医学 肥胖医学
- 病理学 病理学 病理学
背景情况:
- 肥胖是慢性病 (CKD) 进展的重要危险因素.
- 它通过血液动力学,结构和代谢变化导致损伤.
- 肥胖相关的淋巴结膜病变 (ORG) 的特点是肥胖和淋巴结膜病变,通常与FSGS有关.
研究的目的:
- 提供ORG的基础机制的全面概述.
- 探索目前在识别ORG的诊断挑战.
- 讨论ORG管理的治疗策略,包括体重管理和新的治疗方法.
主要方法:
- 关于肥胖和脏疾病的现有文献的综述.
- 对肥胖相关的淋巴细胞病变的病理发现的分析.
- 综合当前的诊断标准和治疗方法.
主要成果:
- 肥胖会诱导诸如血球巨和细分血球硬化等变化,但并不总是特定于ORG.
- ORG与其他导致脏质量减少的疾病具有共同的病理特征.
- 由于ORG.的非病理学特征,存在诊断挑战.
结论:
- 肥胖相关的淋巴细胞病变是一种重要的临床实体,由肥胖相关的病理生理学变化驱动.
- 有效的ORG管理需要通过改变生活方式和药理干预来解决肥胖问题.
- 对向治疗的进一步研究对于改善ORG患者的治疗结果至关重要.
更多相关视频
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Drug Dosing: Obese Patients
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution